• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon

Predicting Vascular Inflammation in High-throughput and Multiplex Assays

On-demand Webinar

Inflammation is an essential mechanism that helps fight off acute infections. The vasculature plays an integral role in inflammatory processes by moving around and transporting different types of cells, such as immune cells, chemokines and cytokines. Chronic inflammation may increase the risk of cardiovascular diseases, such as atherosclerosis and endothelial dysfunction, by having an effect on the endothelium which influences functions such as vascular tone and barrier integrity. To screen targets and develop drugs to treat chronic vascular inflammation, it is critical to create models that recapitulate changes in vascular barrier permeability in inflammatory conditions as well as develop methods to accurately quantify the model’s barrier integrity.

Organ-on-chip technology has facilitated the development of 3D vasculature in vitro models that have allowed the incorporation of key mechanical, chemical and biological factors. Join us this June 20th and see how the OrganoPlate® was used to model immune cell interaction in endothelial inflammation to establish a model ideal for routine target screening towards the treatment of chronic vascular inflammation.

In this webinar, you will:

  • Discover the high-throughput of the OrganoPlate platform and its compatibility to multiplex multiple assays
  • Learn how we utilized the OrganoPlate to model vascular inflammation to study cardiovascular diseases
  • Explore real-time barrier resistance measurements using the OrganoTEER® to detect small changes in barrier in response to inflammatory stimuli



Watch the webinar here



Haley Ehlers is a Marie Sklodowska-Curie fellow at the LogicLab consortium and Early-Stage Researcher affiliated with MIMETAS. Previously, she studied biomedical engineering, specializing in regenerative medicine at California Polytechnic State University, in California, USA. In her current role, she focuses on establishing and developing arterial models in the OrganoPlate, MIMETAS high throughput organ-on-chip platform.



Arya Lekshmi Nair is a Marie Sklodowska-Curie fellow at the Entrain consortium and Early Stage Researcher affiliated with MIMETAS. She received her Bachelor's Degree in Biomedical Engineering from SRM University, India and her Master's Degree in Biomedical Technologies from Eberhard Karls University of Tübingen, Germany. At MIMETAS, she focuses on establishing and developing human blood-brain barrier and neurovascular unit models in the OrganoPlate.




May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all